Showing results (691-700 of 27,679) with videos related to

Sort By:
Pageof 2,768
Vaccine|November 22, 2018
Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigensRitah Nakiboneka, Susan Mugaba, Betty O Auma, et al.
Vaccine|November 25, 2018
Mandatory policies for influenza vaccination: Views of managers and healthcare workers in EnglandMartine Stead, Nathan Critchlow, Douglas Eadie, et al.
Vaccine|November 19, 2018
Association between patient reminders and influenza vaccination status among childrenKatherine E Kahn, Tammy A Santibanez, Yusheng Zhai, et al.
Vaccine|November 26, 2018
The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpesDavid I Bernstein, Derek A Pullum, Rhonda D Cardin, et al.
Vaccine|November 26, 2018
Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South AfricaMeredith L McMorrow, Stefano Tempia, Sibongile Walaza, et al.
Vaccine|March 9, 2019
Cost-effectiveness of adult pneumococcal vaccination policies in underserved minorities aged 50-64 years compared to the US general populationAngela R Wateska, Mary Patricia Nowalk, Chyongchiou J Lin, et al.
Vaccine|February 14, 2021
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of ageBrian J Ward, Annie Séguin, Julie Couillard, et al.
Vaccine|February 14, 2021
Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in AustraliaJialing Lin, Timothy Dobbins, James G Wood, et al.
Vaccine|January 23, 2021
Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccinesRebecca L Brocato, Steven A Kwilas, Matthew D Josleyn, et al.
Vaccine|January 23, 2021
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritizationMichele Kohli, Michael Maschio, Debbie Becker, et al.
Pageof 2,768